Emerging options with coxib therapy

Article Type
Changed
Fri, 12/07/2018 - 12:25
Display Headline
Emerging options with coxib therapy
Article PDF
Author and Disclosure Information

Mark J. Lema, MD, PhD
Department of Anesthesiology, State University of New York at Buffalo School of Medicine, Buffalo, NY

Correspondence: Mark J. Lema, MD, PhD, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263; e-mail: mlema@acsu.buffalo.edu or mark.lema@roswellpark.org

The author has indicated that he has been a consultant for Merck and Purdue and is on the speakers’ bureaus of Merck and Purdue.

Publications
Page Number
SI76-SI84
Author and Disclosure Information

Mark J. Lema, MD, PhD
Department of Anesthesiology, State University of New York at Buffalo School of Medicine, Buffalo, NY

Correspondence: Mark J. Lema, MD, PhD, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263; e-mail: mlema@acsu.buffalo.edu or mark.lema@roswellpark.org

The author has indicated that he has been a consultant for Merck and Purdue and is on the speakers’ bureaus of Merck and Purdue.

Author and Disclosure Information

Mark J. Lema, MD, PhD
Department of Anesthesiology, State University of New York at Buffalo School of Medicine, Buffalo, NY

Correspondence: Mark J. Lema, MD, PhD, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263; e-mail: mlema@acsu.buffalo.edu or mark.lema@roswellpark.org

The author has indicated that he has been a consultant for Merck and Purdue and is on the speakers’ bureaus of Merck and Purdue.

Article PDF
Article PDF
Page Number
SI76-SI84
Page Number
SI76-SI84
Publications
Publications
Article Type
Display Headline
Emerging options with coxib therapy
Display Headline
Emerging options with coxib therapy
Citation Override
Cleveland Clinic Journal of Medicine 2002 April;69(suppl 1):SI76-SI84
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media